Study of galectin-9 as novel biomarker of activity and therapeutic agent in IgA nephropathy
Not Applicable
Recruiting
- Conditions
- IgA nephropathy
- Registration Number
- JPRN-UMIN000015551
- Lead Sponsor
- Kagawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under age 16 and over 80. Patients who do not agree to participate in the study. Patients decided by the doctor to be unsuitable to the study other than above.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary protein, hematuria, serum creatinine, estimated GFR, histological findings
- Secondary Outcome Measures
Name Time Method